Results 11 to 20 of about 354,584 (265)
Tumor immune microenvironment lncRNAs [PDF]
Briefings in Bioinformatics, 2021 AbstractLong non-coding ribonucleic acids (RNAs) (lncRNAs) are key players in tumorigenesis and immune responses. The nature of their cell type-specific gene expression and other functional evidence support the idea that lncRNAs have distinct cellular functions in the tumor immune microenvironment (TIME).
Eun-Gyeong Park +4 more
openaire +3 more sources
Pyroptosis, metabolism, and tumor immune microenvironment [PDF]
Clinical and Translational Medicine, 2021 AbstractIn response to a wide range of stimulations, host cells activate pyroptosis, a kind of inflammatory cell death which is provoked by the cytosolic sensing of danger signals and pathogen infection. In manipulating the cleavage of gasdermins (GSDMs), researchers have found that GSDM proteins serve as the real executors and the deterministic ...
Tiantian Du +8 more
openaire +3 more sources
Vascular Microenvironment, Tumor Immunity and Immunotherapy [PDF]
Frontiers in Immunology, 2021 Immunotherapy holds great promise for treating cancer. Nonetheless, T cell-based immunotherapy of solid tumors has remained challenging, largely due to the lack of universal tumor-specific antigens and an immunosuppressive tumor microenvironment (TME) that inhibits lymphocyte infiltration and activation.
Zachary Lamplugh, Yi Fan
openaire +3 more sources
Role of the tumor immune microenvironment in tumor immunotherapy (Review)
Oncology Letters, 2021 Tumor immunotherapy is considered to be a novel and promising therapy for tumors and it has recently become a hot research topic. The clinical success of tumor immunotherapy has been notable, but it has been less than totally satisfactory because tumor immunotherapy has performed poorly in numerous patients although it has shown appreciable efficacy in
Zhou, Changsheng +4 more
openaire +3 more sources
Tumor Immune Microenvironment in Gynecologic Cancers
Cancers, 2023 Gynecologic cancers have varying response rates to immunotherapy due to the heterogeneity of each cancer’s molecular biology and features of the tumor immune microenvironment (TIME). This article reviews key features of the TIME and its role in the pathophysiology and treatment of ovarian, endometrial, cervical, vulvar, and vaginal cancer. Knowledge of
Daniel Margul +2 more
openaire +2 more sources
Monitoring immune responses in the tumor microenvironment [PDF]
Current Opinion in Immunology, 2016 Immune monitoring in the tumor microenvironment allows for important insights into immune mechanisms of response and resistance to various cancer treatments; however clinical challenges exist using current strategies. Significant questions remain regarding monitoring of archival versus fresh tissue, assessment of static versus dynamic markers ...
Jennifer A, Wargo +3 more
openaire +2 more sources
Frontiers in Oncology, 2023 Triple-negative breast cancer (TNBC) is one of the most aggressive breast cancer subtypes and is characterized by abundant infiltrating immune cells within the microenvironment. As standard care, chemotherapy remains the fundamental neoadjuvant treatment
Gang Wang +10 more
doaj +1 more source
Systemic Immune Dysregulation Correlates With Clinical Features of Early Non-Small Cell Lung Cancer
Frontiers in Immunology, 2022 BackgroundSystemic immune dysregulation correlates with cancer progression. However, the clinical implications of systemic immune dysregulation in early non-small cell lung cancer (NSCLC) remain unclear.MethodsUsing a panel of 9 markers to identify 12 ...
Zhixing Hao +21 more
doaj +1 more source
The Immune Consequences of Lactate in the Tumor Microenvironment [PDF]
, 2020 The tumor microenvironment consists of complex and dynamic networks of cytokines, growth factors, and metabolic products. These contribute to significant alterations in tissue architecture, cell growth, immune cell phenotype, and function. Increased glycolytic flux is commonly observed in solid tumors and is associated with significant changes in ...
Harmon, Cathal +2 more
openaire +3 more sources
Immune suppressive mechanisms in the tumor microenvironment [PDF]
Current Opinion in Immunology, 2016 Effective immunotherapy, whether by checkpoint blockade or adoptive cell therapy, is limited in most patients by a key barrier: the immunosuppressive tumor microenvironment. Suppression of tumor-specific T cells is orchestrated by the activity of a variety of stromal myeloid and lymphoid cells.
Munn, David H, Bronte, Vincenzo
openaire +2 more sources